Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,07 USD | -5,91% |
|
-15,25% | -50,71% |
Vakgebied
Aantal werknemers: 9
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James Sapirstein
CEO | Chief Executive Officer | 63 | 08-10-19 |
Sarah Romano
DFI | Director of Finance/CFO | 44 | 01-03-22 |
Amy Chandler
CMP | Compliance Officer | 56 | - |
Martin Krusin
PRN | Corporate Officer/Principal | - | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 78 | 03-03-17 | |
Ed Borkowski
BRD | Director/Board Member | 64 | 01-05-15 |
Alastair Riddell
BRD | Director/Board Member | 74 | 01-09-15 |
James Sapirstein
CEO | Chief Executive Officer | 63 | 08-10-19 |
Mary Coelho
BRD | Director/Board Member | 62 | 11-08-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 750 090 | 2 594 361 ( 94,34 %) | 0 | 94,34 % |
Bedrijfsgegevens
First Wave Biopharma, Inc.
777 Yamato Road Suite 502
33431, Boca Raton
+561 589 7020
http://www.firstwavebio.com![Adres Entero Therapeutics, Inc.(ENTO)](https://cdn.zonebourse.com/static/address/30506551.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-50,71% | 5,12 mln. | |
+40,80% | 53,67 mld. | |
+35,79% | 38,86 mld. | |
-8,05% | 38,76 mld. | |
-8,98% | 27,27 mld. | |
+10,69% | 25,91 mld. | |
-16,21% | 20,29 mld. | |
+31,00% | 12,78 mld. | |
+28,51% | 12,18 mld. | |
-1,67% | 11,96 mld. |
- Beurs
- Aandelen
- Koers ENTO
- Onderneming Entero Therapeutics, Inc.